Astal Laboratories Ltd vs Sandu Pharmaceuticals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 14, 2026

Key Highlights

The Latest Trading Price of Astal Laboratories Ltd is ₹ 77.28 as of 12 Jun 15:30 . The P/E Ratio of Astal Laboratories Ltd is 0 as of March 2023 .The P/E Ratio of Sandu Pharmaceuticals Ltd is 33.3 as of March 2023 . The Market Cap of Astal Laboratories Ltd is ₹ 0 crore as of March 2023 .The Market Cap of Sandu Pharmaceuticals Ltd is ₹ 50.43 crore as of March 2023 . The revenue of Astal Laboratories Ltd for the Mar '26 is ₹ 134.15 crore as compare to the Dec '25 revenue of ₹ 52.27 crore. This represent the growth of 156.65% The revenue of Sandu Pharmaceuticals Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Astal Laboratories Ltd for the Mar '26 is ₹ 10.29 crore as compare to the Dec '25 ebitda of ₹ 3.59 crore. This represent the growth of 186.63% The ebitda of Sandu Pharmaceuticals Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Astal Laboratories Ltd changed from ₹ 2.74 crore to ₹ 7.68 crore over 3 quarters. This represents a CAGR of 295.20% The net profit of Sandu Pharmaceuticals Ltd changed from ₹ 0.17 crore to ₹ 0 crore over 6 quarters. This represents a CAGR of -100.00% The Dividend Payout of Astal Laboratories Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Sandu Pharmaceuticals Ltd changed from 36.33 % on March 2021 to 49.86 % on March 2025 . This represents a CAGR of 6.54% over 5 years .

About Astal Laboratories Ltd

Astal Laboratories Limited was formerly incorporated as a public company limited by shares on August 03, 1993 in the name of Macro International Limited.
The Company was taken over under SEBI takeover guidelines in 2022 and the main objects of the Company was changed to 'Manufacture and Sales of Pharmaceutical Intermediates and Bulk Drugs'.
Subsequently the name of the Company was changed to Astal Laboratories Limited in May, 2024.
The Company is now a subsidiary of Aceso Research Labs LLP. The Company was promoted by the Kanpur based business house of Parasrampurias.
The Company set up a departmental store at Plaza Kalpana, Birhana Road, Kanpur, offering products such as readymade garments, electronic items, leather items, stationery, books, fast food centre etc. During 1996-97, the departmental store project succeeded, only Saree Division and Archies Card Division was in operation.

About Sandu Pharmaceuticals Ltd

Sandu Pharmaceuticals Limited (SPL) was established in 1987.
The Company is mainly engaged in the business of manufacturing and trading of Ayurvedic medicines under the brand name 'SANDU' and is having a plant unit in Goa. SPL came out with a public issue of 17.70 lac equity shares at par, aggregating Rs 1.77 cr, in Sep.'94, to part-finance its new project in Goa costing Rs 7.28 cr to manufacture ayurvedic medicines and formulations.
This plant employs the latest material handling systems and other modern machinery and has the most hygienic production facilities to attain the highest possible quality standards.
Ayurvedic products have a very good market in India and abroad due to their minimal side effects. The company commenced commercial production of Ayurvedic Medicines & Formulations, at the Goa plant in 1996-97.

FAQs for the comparison of Astal Laboratories Ltd and Sandu Pharmaceuticals Ltd

Which company has a larger market capitalization, Astal Laboratories Ltd or Sandu Pharmaceuticals Ltd?

Market cap of Astal Laboratories Ltd is 338 Cr while Market cap of Sandu Pharmaceuticals Ltd is 40 Cr

What are the key factors driving the stock performance of Astal Laboratories Ltd and Sandu Pharmaceuticals Ltd?

The stock performance of Astal Laboratories Ltd and Sandu Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Astal Laboratories Ltd and Sandu Pharmaceuticals Ltd?

As of June 14, 2026, the Astal Laboratories Ltd stock price is INR ₹77.28. On the other hand, Sandu Pharmaceuticals Ltd stock price is INR ₹41.61.

How do dividend payouts of Astal Laboratories Ltd and Sandu Pharmaceuticals Ltd compare?

To compare the dividend payouts of Astal Laboratories Ltd and Sandu Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.